Back to Search Start Over

Eisai starts lorcaserin phase three clinical study

Source :
M2 Pharma. October 1, 2020
Publication Year :
2020

Abstract

M2 PHARMA-October 1, 2020-Eisai starts lorcaserin phase three clinical study (C)2020 M2 COMMUNICATIONS Following consultation with the United States Food and Drug Administration (FDA), Eisai Inc, a Japan-based pharmaceutical company, [...]

Subjects

Subjects :
United States. Food and Drug Administration
Eisai Inc. -- Product development
Clinical trials -- Research
Pharmaceutical industry -- Product development
Lorcaserin -- Research
Chemistry

Details

Language :
English
Database :
Gale General OneFile
Journal :
M2 Pharma
Publication Type :
News
Accession number :
edsgcl.637037380

Tools

Authors Abstract Subjects Details